KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $84.0 million.

  • Elevance Health's Cash from Operations fell 8810.2% to $84.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.3 billion, marking a year-over-year decrease of 2613.64%. This contributed to the annual value of $4.3 billion for FY2025, which is 2613.64% down from last year.
  • As of Q4 2025, Elevance Health's Cash from Operations stood at $84.0 million, which was down 8810.2% from $1.1 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Cash from Operations registered a high of $6.5 billion during Q1 2023, and its lowest value of -$3.0 billion during Q4 2023.
  • For the 5-year period, Elevance Health's Cash from Operations averaged around $1.7 billion, with its median value being $2.0 billion (2023).
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 19078.95% in 2022, then skyrocketed by 35950.78% in 2025.
  • Elevance Health's Cash from Operations (Quarter) stood at $1.7 billion in 2021, then plummeted by 190.79% to -$1.5 billion in 2022, then plummeted by 95.72% to -$3.0 billion in 2023, then soared by 123.76% to $706.0 million in 2024, then plummeted by 88.1% to $84.0 million in 2025.
  • Its last three reported values are $84.0 million in Q4 2025, $1.1 billion for Q3 2025, and $2.1 billion during Q2 2025.